Delivery Order SPE2DB22D9143-SPE2DB24FZC72

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,321.50 firm fixed-price contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a prescription pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $12,964.50, is for the supply of XTANDI 40 MG CAPSULE 120S, a branded pharmaceutical product. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,868.10 contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a prescription medication, and is not associated with any set-aside program. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that allows...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,934.05 firm fixed-price delivery order is for the supply of XTANDI 40 MG CAPSULE 120S, with a performance period ending on July 19, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $12,934.05 contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product, with a ceiling value of $12,934.05 and a completion date of March 20, 2024. The award is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, valued at up to $4,999,999 that DMS Pharmaceutical Group holds with DLA. This IDV...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,622.72, is for the delivery of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,311.35 contract is for the supply of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $4,311.35 contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue firm fixed-price delivery orders for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,934.05 Firm Fixed Price delivery order contract is for the provision of XTANDI 40 MG CAPSULE 120S to support the recurring medical supply needs of military health facilities. This award is under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which...
  • SPE2DB22D9143
    Indefinite Delivery Contract
  • SPE2DB22D9143-SPE2DB24FZC72
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,934.05 firm fixed-price contract is for the supply of XTANDI 40 MG CAPSULE 120S, a prescription medication.

The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical requirements of the Department of Defense healthcare system through this contract vehicle.

The contract has no set-aside designation, leveraging DMS Pharmaceutical Group's status as a woman-owned small business to secure direct awards for pharmaceutical Prime Vendor programs supporting military medical facilities globally.

Generated 12/3/24, 10:08 AM